Clinical Trial Update: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

View source ↗

Summary

The INSPIRIS RESILIA Aortic Valve Valve-in-Valve Surveillance Study (NCT04902053) is currently suspended. It concerns patients undergoing aortic valve replaceme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• INSPIRIS RESILIA Aortic Valve

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Replacement | Status: SUSPENDED